Orion Oyj ORNBV

HEL: ORNBV | ISIN: FI0009014377 11/12/2024

42,99 EUR (-1,74%)

(-1,74%) 11/12/2024

Grafiek Orion Oyj

Grafiek Orion Oyj

1 dag1d -1,74%
1 week1w -4,47%
1 maand1m -2,49%
3 maanden3m -8,73%
6 maanden6m 14,85%
1 jaar1j 19,15%
5 jaar5j 6,62%

Orion Oyj in het nieuws

Toon enkel gratis nieuws

27 november 2024 · 142,701 Orion Corporation A shares converted into B shares · Persbericht

22 november 2024 · Orion Research Foundation grants EUR 1,109,000 for research in 2025 · Persbericht

19 november 2024 · Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies · Persbericht

1 november 2024 · Orion Corporation: Managers’ transactions – Henrik Stenqvist · Persbericht

29 oktober 2024 · Orion Group Interim Report January–September 2024 · Persbericht

24 oktober 2024 · Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule · Persbericht

15 oktober 2024 · Orion publishes Interim Report for January–September 2024 and holds a webcast on 29 October 2024 · Persbericht

14 oktober 2024 · Orion’s collaboration partner Bayer submits application for third indication of darolutamide in the EU · Persbericht

30 september 2024 · Orion’s near-term climate targets approved by the Science Based Targets initiative · Persbericht

26 september 2024 · Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe